Review
Pharmacology & Pharmacy
Caiyi Long, Haoyue Feng, Zheng Liu, Zihan Li, Jun Liu, Yayi Jiang, Rensong Yue
Summary: This study conducted a network meta-analysis to evaluate the efficacy and safety of traditional Chinese medicine injections (TCMIs) in the treatment of diabetic kidney disease (DKD). The results showed that TCMIs combined with alprostadil injection (PGE1) were more effective than PGE1 alone. PGE1+HQI and PGE1+SKI were found to be the most effective treatments. However, further investigation on the safety of TCMI treatment is needed, and larger-scale, double-blind, multicentre RCTs are required to validate these findings.
FRONTIERS IN PHARMACOLOGY
(2023)
Review
Infectious Diseases
Meng-Ting Li, Jia Wang, Jia Hu, Han-Biao Wu, Wei-Shang Deng, Zhi-Kun Qiu, Ji-Sheng Chen
Summary: This study assessed the efficacy and safety of traditional Chinese medicine injections (TCMIs) in the treatment of viral pneumonia. The results showed that TCMIs combined with conventional antiviral drugs (CAD) were more effective and safer than CAD monotherapy.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
(2022)
Review
Plant Sciences
Zhenyu Zhao, Yanda Li, Liangyun Zhou, Xiuteng Zhou, Bowen Xie, Wenjin Zhang, Jiahui Sun
Summary: Traditional Chinese medicine (TCM) has shown significant effectiveness in preventing and treating COVID-19, with the ability to prevent iatrogenic infections and a high national participation rate in China. It is currently the best choice for the treatment and prevention of COVID-19 and is expected to be promoted globally.
Review
Environmental Sciences
Yuwen Chen, Junyi Zou, Hui Sun, Jihong Qin, Jiyuan Yang
Summary: In recent decades, there has been a comprehensive review of public reports on metals in traditional Chinese medicinal materials (TCMM). The distribution of metals in different medicinal parts has been analyzed, with lead mainly distributed in leaves and cadmium mainly distributed in flowers and fruits, stems and leaves. The risk of metal residues is highest in the Qinghai-Tibet Plateau, south China, and southwest China, with herba-type medicinal materials having the highest risk of metal content.
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
(2021)
Review
Integrative & Complementary Medicine
Haiyang Chen, Yu He
Summary: This article introduces the application of machine learning methods in the field of traditional Chinese medicine, including classification, regression, clustering, and dimensionality reduction. It also discusses the specific models used in each category and the differences in function and features when applied to different fields.
AMERICAN JOURNAL OF CHINESE MEDICINE
(2022)
Review
Geriatrics & Gerontology
Chao-yang Guo, Yun-jing Ma, Shu-ting Liu, Ran-ran Zhu, Xiao-ting Xu, Zhen-rui Li, Lei Fang
Summary: This systematic review analyzes the current evidence for the effect of traditional Chinese medicine (TCM) on sarcopenia. The results suggest that TCM has a positive impact on muscle strength and physical function, but the evidence for its effect on muscle mass is inconclusive. The low quality of included studies and issues with study design limit the reliability of the results. Future high-quality research is needed to determine the effectiveness of acupuncture and other therapies for treating sarcopenia.
FRONTIERS IN AGING NEUROSCIENCE
(2022)
Review
Integrative & Complementary Medicine
Hui Zhao, Man He, Meng Zhang, Qiang Sun, Sha Zeng, Li Chen, Han Yang, Maolun Liu, Shan Ren, Xianli Meng, Haibo Xu
Summary: The text discusses the pathogenesis of colorectal cancer, the types and functions of gut microbiota, and the research on traditional Chinese medicine in treating colorectal cancer by regulating the gut microbiota. It emphasizes the importance of regulating the gut microbiota for disease treatment.
AMERICAN JOURNAL OF CHINESE MEDICINE
(2021)
Review
Pharmacology & Pharmacy
Xiaoying Ling, Xun Sun, Huimin Kong, Shanshan Peng, Zheng Yu, Jiali Wen, Bin Yuan
Summary: This meta-analysis indicated that Chinese herb medicine (CHM) showed benefits in improving clinical efficacy, shortening antipyretic, cough disappearance, lung rale disappearance, and lung X-ray infiltrates disappearance time, as well as reducing TNF-alpha level for children and adolescents with RMPP. However, due to limitations in quality and quantity of included studies, the efficacy of CHM in treating RMPP remains inconclusive. More large-scale, double-blind, well-designed, randomized controlled trials are needed for further research.
FRONTIERS IN PHARMACOLOGY
(2021)
Review
Plant Sciences
Liangshuai Liu, Heping Li, Guosheng Tan, Zhenjiang Ma
Summary: This study reviewed the use of traditional Chinese herbal medicine in treating amenorrhea caused by antipsychotic drugs and conducted a meta-analysis. The results showed that Chinese herbal medicine can effectively treat this condition, although it may take a long time to achieve satisfactory effectiveness.
JOURNAL OF ETHNOPHARMACOLOGY
(2022)
Review
Pharmacology & Pharmacy
Jian-Ning Guo, Xue Bai, Hong-Xian Zhang, Ning Zhang, Jun-Ming Liang, Zi-Yi Guo, Xia Cui
Summary: This study evaluated the efficacy and safety of Chinese herbal medicine (CHM) in the treatment of pediatric pneumonia convalescence using a meta-analysis approach. The results showed that CHM combined with Western medicine or used alone improved the clinical effectiveness, reduced cough relief time, lung rales disappearance time, and length of hospital stay in children with pneumonia convalescence. However, there was no significant difference in the incidence of adverse reactions.
FRONTIERS IN PHARMACOLOGY
(2022)
Review
Public, Environmental & Occupational Health
Nan Yang, Huihui Zhang, Taoyi Deng, Jeff Jianfei Guo, Ming Hu
Summary: This study identified 431 published pharmacoeconomic articles on Traditional Chinese Medicine, with major concerns regarding study design, inappropriate pharmacoeconomic evaluation, insufficient sample size, or non-scientific assessment. Enhanced methodological training and cooperation, development of a targeted pharmacoeconomic evaluation guideline, and proposal of a reasonable health outcome index are needed for improving quality of future studies.
FRONTIERS IN PUBLIC HEALTH
(2021)
Review
Pharmacology & Pharmacy
Yingying Peng, Zhe Chen, Huanmin Li, Yaowei Han, Dan Sun, Yanjiao Li, Xiaoxia Wu, Hongxiang Chen, Xinmin Li
Summary: This study compared the efficacy and safety of traditional Chinese medicine injections (TCMIs) combined with oseltamivir (TCMIs + oseltamivir) versus oseltamivir alone in the treatment of influenza. The results showed that some TCMIs + oseltamivir combinations were more effective than oseltamivir alone in reducing fever and cough duration. However, the overall therapeutic efficacy and safety remained inconclusive.
FRONTIERS IN PHARMACOLOGY
(2022)
Review
Integrative & Complementary Medicine
Xiaomin Kang, De Jin, Linlin Jiang, Yuqing Zhang, Yuehong Zhang, Xuedong An, Liyun Duan, Cunqing Yang, Rongrong Zhou, Yingying Duan, Yuting Sun, Fengmei Lian
Summary: This study systematically reviewed the efficacy of traditional Chinese medicine (TCM) for COVID-19 and discussed its possible mechanisms. The included studies showed that TCM could reduce the proportion of patients progressing to severe cases and the mortality rate of severe or critical patients. Additionally, TCM could relieve clinical symptoms, shorten hospital stay, and improve laboratory indicators.
Review
Medicine, General & Internal
Xiaozheng Wu, Wen Li, Zhong Qin, Lei Xue, Gao Huang, Zhenliang Luo, Yunzhi Chen
Summary: The study evaluated the efficacy and safety of traditional Chinese medicine (TCM) assisted in conventional treatment for mild and common COVID-19 patients. Results showed that TCM can improve the clinical effective rate and main symptoms, with specific TCM remedies like Toujie Quwen, Shufeng Jiedu, and Lianhua Qingwen showing the best performance. In terms of safety, Shufeng Jiedu and Lianhua Qingwen had advantages over conventional treatment.
Review
Pharmacology & Pharmacy
Wei Shen, Xueming Fan, Liuding Wang, Yunling Zhang
Summary: This study aimed to evaluate the effectiveness and safety of Traditional Chinese Medicine (TCM) in the treatment of Post-stroke cognitive impairment (PSCI). The results showed that TCM adjuvant therapy can improve cognitive function and daily living ability in PSCI patients. However, due to methodological flaws and herbal heterogeneity, the evidence only supports the limited use of TCM in PSCI patients. Further rigorous randomized controlled trials (RCTs) are needed to confirm the efficacy and safety of TCM.
FRONTIERS IN PHARMACOLOGY
(2022)
